CAREER: mON-SHOT : Training Environmental Engineers to Track the Fate of Emerging Therapeu — NSF Award to University of Colorado a
Using modified short strands of genetic material, known as oligonucleotides, to treat disease is revolutionizing medicine. Many different types of oligonucleotides are being used to treat common and rare diseases. These therapeutics remain active and stable in the body. Some pass through patients into wastewater system
| Award title | CAREER: mON-SHOT : Training Environmental Engineers to Track the Fate of Emerging Therapeu |
|---|---|
| Award ID | 2542554 |
| Awardee | University of Colorado at Boulder |
| City | BOULDER |
| State | CO |
| Amount obligated | $597,676 |
| Principal investigator | Cresten Mansfeldt |
| Program | EnvE-Environmental Engineering |
| Start date | 07/01/2026 |
| Abstract | Using modified short strands of genetic material, known as oligonucleotides, to treat disease is revolutionizing medicine. Many different types of oligonucleotides are being used to treat common and rare diseases. These therapeutics remain active and stable in the body. Some pass through patients into wastewater systems. However, there are no tools available to track these genetic materials in water systems or to guide wastewater treatment approaches. This project will develop methods to detect |
| Source | NSF Awards |
$799/mo
Try NSFGrants →